Miracor Medical Systems GmbH has developed and will commercialize the Pressure-controlled Intermittent Coronary Sinus Occlusion (PICSO™) technology for heart attack patients. The technology is in European clinical trials and holds the promise to improve outcomes for patients undergoing coronary revascularization using a stent. The PICSO™ technology redistributes blood flow into the damaged tissue of the heart which can reduce and revitalize the damaged tissue.
 

news


09/12/09 Miracor Completes First Patients with New Devices
27/10/09 START-UP article on Miracor Medical Systems
22/09/09 PICSO presented during TCT 2009

for more news go to our News page. You may also sign up for receiving news directly be providing your e-mail address: 
Last updated: 08/02/10